MedPath

ationwide Observational Study for Persistent Atrial Fibrillation Patients with Treatment by SATAKE-HotBalloon Catheter

Not Applicable
Recruiting
Conditions
Drug-resistant recurrent symptomatic persistent atrial fibrillation
Registration Number
JPRN-jRCT1032230149
Lead Sponsor
Yamane Teiichi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
500
Inclusion Criteria

1. Patients over the age of 18
2. Patients scheduled for ablation with SATAKE-HotBalloon catheter for persistent atrial fibrillation

Exclusion Criteria

1. Patients diagnosed with a life expectancy of less than 1 year due to some disease
2. Patients who requested refusal regarding the use of information in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
12 months postoperative success rate (Including touch-up cases)
Secondary Outcome Measures
NameTimeMethod
1. Acute phase success rate (including touch-up cases)<br> Percentage of study subjects with isolated pulmonary veins (RSPV, RIPV, LSPV, LIPV)<br> Isolated lungs for ablated pulmonary veins (RSPV, RIPV, LSPV, LIPV) Percentage of veins<br><br>Success or failure of isolation: Successful if the potential is 0.1 mV or less or if the pulmonary vein potential and the left atrial potential are not synchronized.<br><br>2. 12 months postoperative safety<br> Occurrence of all adverse events related to catheter ablation during the observation period
© Copyright 2025. All Rights Reserved by MedPath